Register entry

Zevra Therapeutics, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
3
Live patents
15
Countries
0
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 human prescription drug. By marketing category: NDA 3.

Dosage formNDCs
tablet3
RouteNDCs
oral3
Labeller name on the listingNDCs
zevra therapeutics, inc.3
Exclusivity

Patents and exclusivities

15
PatentProductCoversExpiry
8748413APADAZacetaminophen; benzhydrocodone hydrochloridesubstance, productJul 2030
8828978APADAZacetaminophen; benzhydrocodone hydrochlorideproductJul 2030
9132125APADAZacetaminophen; benzhydrocodone hydrochloridesubstance, productJul 2030
9549923APADAZacetaminophen; benzhydrocodone hydrochloridesubstance, productJul 2030
8461137APADAZacetaminophen; benzhydrocodone hydrochloridesubstance, productFeb 2031
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
APADAZBenzhydrocodone and Acetaminophentablet, oral70040-0145NDA
APADAZBenzhydrocodone and Acetaminophentablet, oral70040-0167NDA
APADAZBenzhydrocodone and Acetaminophentablet, oral70040-0189NDA
Enquiry

Common questions

Is Zevra Therapeutics, Inc. FDA approved?
Zevra Therapeutics, Inc. holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Zevra Therapeutics, Inc. make?
3 products are listed under Zevra Therapeutics, Inc. in the openFDA NDC Directory, most often as tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.